Posts

therapist

US Task Force Recommends All Adults Under 65 Be Screened for Anxiety

The U.S. Preventative Services Task Force recommended that all physicians screen adult patients under 65 for anxiety. The move was motivated by the country’s mental health epidemic in the wake of the pandemic.

The USPSTF is a panel of medical experts appointed by the Department of Health and Human Services. The panel said the recommendation was brought forward to prevent mental health disorders from going undetected or untreated for a long time. Over the last few years, people were more stressed and depressed, and anxiety levels went through the roof.

Between August 2020 to February 2021, adults with symptoms of anxiety or depression increased from 36.4% to 41.5%. According to the World Health Organization, anxiety and depression increased by 25% worldwide. In 2021, 1 in 4 adults aged 18 to 44 received treatment for mental health.

The task force recognizes anxiety as “characterized by greater duration or intensity of a stress response over everyday events.”

Clinical psychologist Dr. Lori Pbert, who is on the task force, says that Americans have been remarkably stressed out after a series of stressors like COVID-19, inflation, death of loved ones, fear of illness and crime rates. According to the NYTimes and CNN, Dr. Pbert said, “our only hope is that our recommendations throw a spotlight on the need to create greater access to mental health care — and urgently.”

“Our hope is that by raising awareness of these issues and having recommendations for clinicians, that we’ll be able to help all adults in the United States, including those who experience disparities.”

Embed from Getty Images

The task force lists generalized anxiety disorder, social anxiety disorder, and agoraphobia under the umbrella of anxiety conditions and recommends screening those who are not already diagnosed with a disorder. The panel also recommended that adults be screened for depression.

Mental health providers appreciated the recommendations but acknowledged that while screening tools are helpful, they are not a diagnosis, and subsequent testing is required to determine if an individual has a clinical disorder. A one-time screening may only be indicative of a temporary stressor. Providers also spoke on the lack of resources to address the issue on a wide scale.

Dr. Jeffrey Staab, a psychiatrist and chair of the department of psychiatry and psychology at Mayo Clinic, said the country is “short on mental health resources on all levels — psychiatrists, psychologists and therapists — that’s a real concern.”

“When providers say, ‘You must have a disorder, here, take this,’ we could face an overprescribing problem, but the opposite scenario is that we have lots of people suffering who shouldn’t be. Both outcomes are possible.”

Embed from Getty Images

Dr. Pbert also said the task force’s research showed that people from minority groups are often overlooked in mental health research, contributing to continued systemic inequality both in and outside the medical field.

The primary care practice is currently a missed opportunity for screening. Black and Hispanic people are less likely to be treated for mental health conditions than white people and are more often misdiagnosed when they do receive care. Dr. Pbert said standardized screenings might help reduce those statistics by removing other factors like implicit bias.

The USPSTF made a similar recommendation for children earlier in the year. The task force set the age range to 65 and younger because older adults may produce positive screening results due to the natural aging effects such as fatigue and generalized pain.

The panel will finalize the draft after reviewing public comments and notes submitted before the Oct. 17 deadline. Though the recommendation is not mandatory, many physicians use the panel’s guidance to improve their standard of care.

polio

New York Declares State of Emergency After Finding Polio Virus in Wastewater

New York declared a state of emergency Friday after detecting polio virus in Long Island wastewater. The discovery in Nassau County, Long Island, signals a more extensive virus spread within the state’s population.

In July, Rockland County confirmed the first case of polio in the United States since 1993. The county is less than 50 miles from New York City. Officials began testing waters in surrounding counties shortly after and found the virus in Orange and Sullivan counties’ wastewater.

State Health Commissioner Dr. Mary T Basset warns that one observed case of the paralytic disease usually signals hundreds of asymptomatic infected individuals. Even if an infected individual is asymptomatic, they may be contagious for days to weeks.

“Based on earlier polio outbreaks, New Yorkers should know that for every one case of paralytic polio observed, there may be hundreds of other people infected.”

Embed from Getty Images

Polio is highly contagious. If infected, most people will have mild or no symptoms. A smaller percentage of infected individuals may develop more severe symptoms that affect the brain and spinal cord. According to the state’s health department, “New Yorkers should know that paralysis is the most severe symptom associated with polio because it can lead to permanent disability and death.”

The World Health Organization states that one in 200 infections leads to irreversible paralysis. Among the most vulnerable are children under five, who comprise a large percentage of the infected population.

Gov. Kathy Hochul signed an executive order Friday to expand the medical personnel who can administer the vaccine. EMS workers, midwives and pharmacists will be able to vaccinate individuals. Health care providers will also need to send immunization data to the New York State Department of Health so that officials can determine which counties are at the most risk and have the highest vaccine demand.

Officials are urging the public to vaccinate if they have not already done so. Dr. Basset told the public Friday, “do not wait to vaccinate” and “on polio, we simply cannot roll the dice.”

“If you or your child are unvaccinated or not up to date with vaccinations, the risk of paralytic disease is real.”

Embed from Getty Images

Children can be vaccinated if they are two months or older. The statewide polio vaccination rate sits at around 79%. The counties with contaminated wastewater all had lower rates of vaccinations, and the confirmed case in July was in an unvaccinated adult.

Polio spreads through person-to-person contact. In the 1940s, polio disabled an average of more than 35,000 individuals and caused 15,000 cases of paralysis a year. Due to a widespread vaccine campaign beginning in 1955, polio cases fell to less than 100 in the 1960s.

People most susceptible to infection are those who never had the polio vaccine, who never completed the vaccine regimen or those who will be traveling to areas that could put them at a high risk of catching the virus.

patient

Mysterious Disease Plagues Argentina And Claims Third Victim

An unknown form of pneumonia has been found in Argentina and killed three people and sickened at least six other individuals. 

The individuals who have come down with the new illness have been tested for other pneumonia-causing bugs, including COVID-19 and have all come back as negative.

All the most recent cases have been reported right around the small region of Tucumán, roughly 800 miles from the capital of Buenos Aires.

“It’s obviously concerning but we still need key information on transmission and hopefully [ the] underlying cause,” said Professor Devi Sridhar, chair of global health at Edinburgh University.

Reports from Ministry of Public Health of Tucmán Province stated that the first six cases all had similar symptoms including fevers, muscle pain, abdominal pain and had difficulty breathing.

Embed from Getty Images

“What these patients have in common is the severe respiratory condition with bilateral pneumonia and compromise in [Z-ray] images very similar to COVID, but that is ruled out,” said Tucmán health minister Luis Medina Ruiz. 

The European Centre for Disease Control’s epidemic intelligence team has been looking at and monitoring the rising cases since Tuesday and scientists at the World Health Organization started tracking as well.

Since Tucmán is the only place known to be the origin of the infection, local officials have also been testing the water and air conditioning units to see if there are any factors there as well.

Currently there has been no proof that this mysterious pneumonia has been contagious from person-to-person transmission.

Professor Paul Hunter, a professor in medicine at the University of East Anglia, told the BBC in an interview that it is pretty impossible at this stage to say what the impact of the disease might since it is still so new.

Embed from Getty Images

“These things happen from time to time. Often they just fizzle out, but not always. Sometimes they cause a substantial local outbreak or something even bigger,” said Hunter.

He hopes that within the next few days that the experts who are working on the new disease will have even more answers due to the rapid speed that the tests can give results too. 

Dr. Ruiz has also stated that given the current situation, it would be hard to predict an origin with it only being 11 days since the first case was announced.

Moreover, every person who has come in contact with the disease has has a difference response with the outbreak. 

There is nothing that health officials can do at this point besides wait only because there is still many unknowns that are linked to the disease. 

 

pill

A Single-Dose ‘Polypill’ Found To Be A Life Saving Drug

A three-in-one drug combo was recently found and it helps those who have a history of heart attacks find a new way to stay healthy. 

In a recent clinical study led by Dr. Valentin Fuster, director of Mount Sinai in New York City, he studied roughly 2,499 patients across seven European countries. 

These patients have had a history of type 1 myocardial infarction within the last six months or were over the age of 75 or had a minimum age of 65 with at least one high risk faster.

Embed from Getty Images

A handful of the patients were given the polypill that had aspirin, ramipril and atorvastatin while the other received typical care. The groups were followed over the next three years.

Typically after a patient suffers a heart attack, they are prescribed three different drugs. These usually are aspirin, ramipril or another drug for blood pressure and a cholesterol-lowering drug. 

However, usually less than 50% of patients take their prescriptions as they are prescribed by the doctor. 

“Although most patients initially adhere to treatment after an acute event such as an infarction [tissue death], adherence drops off after the first few months. Our goal was to have an impact right from the start, and most of the patients in the study began taking a simple polypill in the first week after having a heart attack” 

“The results were, frankly, very exciting,” said Fuster. 

After the study, the outcome was overwhelmingly positive. The results found that there was 24% reduction in heart disease or other heart problems.

The new drug also helped reveal that it helped cut the high risk of dying from cardiovascular disease by 33%. 

“The SECURE study findings suggest that the polypill could become an integral element of strategies to prevent recurrent cardiovascular events in patients who have had a heart attack. By simplifying treatment and improving adherence, this approach has the potential to reduce the risk of recurrent cardiovascular disease and death on a global scale,” said Fuster. 

Embed from Getty Images

According to UPI, the polypill that has been used within the study still hasn’t been approved by the US Food and Drug Administration. However, Fuster believes that the positive results from the study could be submitted with an effort to hopefully gain approval.

“Combination pills are easier for the physician and for the patient, and the data is pretty clear – it translates into benefit,” said Dr. Thomas Wang, chair of the department of internal medicine at UT Southwestern Medical Center. 

The combination of the drugs, in this all in one pill, seems to help lead to the improvements and the patients well being, people may be more likely to stay on top of their medications to help them improve their health which is a win win.

run

Study Finds Regular Physical Activity Could Reduce Covid-19 Risk 

According to a data analysis published in the British Journal of Sports Medicine, regular exercise can lower the risk of developing Covid-19 or getting seriously ill when one contracts the virus. The data suggests that about 20 minutes of exercise a day yielded the greatest results. 

The study stated that a weekly total of 150 minutes of moderately intense exercise or 75 minutes of vigorous physical activity would give the greatest results. 

Embed from Getty Images

“Regular physical activity seems to be related to a lower likelihood of adverse Covid-19 outcomes,” the team of researchers wrote. 

“Our analysis reveals that individuals who engage in regular physical activity have a lower likelihood of Sars-CoV-2 infection, Covid-19 hospitalization, severe Covid-19 illness and Covid-19-related death than physically inactive individuals, independent of design and instrument used.”

In general, exercise has a protective effect when it comes to respiratory infections. Regular physical activity reduces one’s chances of obesity, type 2 diabetes, and a multitude of other illnesses, most recently Covid-19. 

The researchers emphasized that the analysis was relatively limited, so the results shouldn’t be taken at face value. The team attempted to quantify the specific threshold of physical activity needed to make an actual difference in lessening the risk of contracting Covid-19, or lessening the severity should one become infected. 

The study observed data from 1.8 million adults, 54% of which were women, and the median age of each individual was 53. 

Embed from Getty Images

The data analysis showed that, overall, “those who included regular physical activity in their weekly routine had an 11% lower risk of infection with Sars-CoV-2, the virus that causes Covid.”

Those individuals also had a 36% lower risk of hospitalization, a 44% lower risk of severe Covid-19, and a 43% lower risk of death from Covid-19. 

The research team also warned that the data was a result of “observational studies, differing study designs, subjective assessments of physical activity levels, and concerned only the Beta and Delta variants of Sars-CoV-2 rather than Omicron, all of which could weaken the findings.”

“There are plausible biological explanations for what we found. Regular moderate-intensity exercise may help to boost the body’s anti-inflammatory responses, as well as cardiorespiratory and muscular fitness, all of which may explain its beneficial effects on Covid-19 severity,” the researchers said. 

“Our findings highlight the protective effects of engaging in sufficient physical activity as a public health strategy, with potential benefits to reduce the risk of severe Covid-19.”

“Given the heterogeneity and risk of publication bias, further studies with standardized methodology and outcome reporting are now needed,” they wrote. 

monkeypox

U.S. Declares Monkeypox A Public Health Emergency

On Thursday, the federal government declared the ongoing monkeypox outbreak — which has now affected 7,012 Americans — a public health emergency in an attempt to help strengthen responses. With that declaration, additional money will be directed toward resources for the virus.

“Ending the monkeypox outbreak is a critical priority for the Biden-Harris Administration,” Department of Health and Human Services (HHS) Secretary Xavier Becerra explained in a release.

Embed from Getty Images

“With today’s declaration we can further strengthen and accelerate our response further,” Becerra said. “We urge every American to take monkeypox seriously and to take responsibility to help us tackle this virus.”

White House National Monkeypox Response Coordinator Robert Fenton emphasized the strategies being deployed against monkeypox are helped by prior learning experiences with outbreaks, such as COVID-19.

“We are applying lessons learned from the battles we’ve fought – from COVID response to wildfires to measles, and will tackle this outbreak with the urgency this moment demands.”

HHS is now able to utilize emergency funds and hire or assign staff to deal with the outbreak. The department also noted work being done in concert with the Food and Drug Administration (FDA) that will help to provide the Jynneos monkeypox vaccinations across the country.

The partnership plans to utilize a “new dose-sparing approach that could increase the number of doses available, up to five-fold.” This sparsing would be accomplished through a shallower injection than the one recommended for Jynneos.

However, the approach would need approval from regulators and another declaration from the federal government altering guidelines on vaccine administration.

The announcement comes as vaccines are seeing struggles with availability. Minnesota has just 3,000 of the 90,000 vaccines needed to help those most at-risk, while California has received just around 37,000 of the 800,000 requested.

Health officials also have concerns that should the shortage not be addressed immediately and effectively, the virus could become far more widespread, marking it as the second public health disaster in a span of over two years.

Embed from Getty Images

HHS has shipped over 602,000 doses of the vaccine, a number that’s up 266,000 from last week, bringing the total amount of allocated vaccines to 1.1 million. The department also announced it’s ordered an additional 150,000 vaccines, which are expected to arrive in September. Similar to most COVID-19 vaccines, Jynneos requires two doses, 28 days apart.

According to the Center for Disease Control’s (CDC) case count, as of Thursday, New York continues to lead all states in cases with 1,748. California sits second with 826 cases, while Florida is third with 577. Just two out of the 50 states (Wyoming and Montana) have no reported cases.

California, New York, and Illinois all declared public health emergencies last week, as did the cities of New York City and San Francisco. Despite the rising cases, no Americans have died, though several deaths have been reported in other countries. In recent times, monkeypox fatality rates have ranged from 3% to 6%.

Monkeypox had previously been declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO) in late July following a substantial global increase. Worldwide, over 26,800 cases in more than 70 countries have been confirmed.

covid

Following Unanimous Vote, CDC Recommends Novavax COVID-19 Vaccine

On Tuesday, a panel of the Center for Disease Control and Prevention’s (CDC) outside vaccine advisors voted to recommend the use of the Novavax COVID-19 vaccination for those 18 and older.

“Novavax’s COVID-19 vaccine, which will be available in the coming weeks, is an important tool in the pandemic and provides a more familiar type of COVID-19 vaccine technology for adults,” the CDC said in a statement.

Embed from Getty Images

Novavax’s vaccine had previously been authorized by U.S. regulators last week, but the CDC’s approval was the final obstacle for it to become available. The agency stressed the importance of multiple options and flexibility for the public.

67.6% of the American population is fully vaccinated, with 79.1% having received at least one dose. However, the CDC stated there are still between 26 million to 37 million adults who have yet to receive a single dosage.

“If you have been waiting for a COVID-19 vaccine built on a different technology than those previously available, now is the time to join the millions of Americans who have been vaccinated,” CDC Director Dr. Rochelle Walensky said.

“With COVID-19 cases on the rise again across parts of the country, vaccination is critical to help protect against the complications of severe COVID-19 disease.” 

The Novavax vaccine is particularly interesting because of how it works in contrast to other COVID-19 vaccines. All vaccines are trained to recognize the virus’ outer coating, the spike protein. Vaccines like Moderna and Pzifer give the body genetic instructions on how to replicate the spike protein.

In contrast, instead of telling the body how to make spike protein copies, the Novavax vaccine delivers copies, made in a lab and packaged into nanoparticles, straight to the body that will help the immune system to respond to the vaccine.

One of the ingredients used in this process is adjuvant. The CDC noted vaccines using protein subunits “have been used for more than 30 years in the United States, beginning with the first licensed hepatitis B vaccine” and later with influenza and whooping cough.

According to a Food and Drug Administration (FDA) report, the vaccine was found to be 90% effective against mild, moderate, and severe disease in Novavax’s Phase 3 trial, which involved 30,000 participants.

Embed from Getty Images

While that study was done before the Delta and Omicron waves, leaving the vaccine’s efficiency against the subvariants unknown, the company also possesses a COVID-19 Omicron vaccine that currently sits in Phase 3.

The hope is that the Novavax vaccine will present familiarity and assurance to those who haven’t received a dosage due to the mRNA technology utilized being unfamiliar.

It’s anyone’s guess as to if that play will work, but more vaccinations of any kind will undoubtedly help to continue curbing a pandemic that’s once again seeing surges in the warm summer months. The country is currently averaging 127,000 new cases per day.

The Novavax vaccine’s initial quantity will be scarce, the Biden Administration told states, which will be unable to start requesting shipments until next week. Additionally, not all providers will carry the vaccine. Given the timeline presented, the Novavax vaccine should start seeing use sometime in August.

monkeypox

According to WHO, Monkeypox Cases Have Risen 77% In A Week

On Thursday, the World Health Organization (WHO) reported a 77% weekly increase in the number of lab-confirmed monkeypox cases, contributing to more than 7,000 total reported cases worldwide in 54 locations.

Due to the rapid increase, WHO Director-General Tedros Adhanom Ghebreyesus said the agency will reconvene a meeting of the committee that will decide on whether to declare the outbreak a Public Health Emergency of International Concern (PHEIC).

The committee previously met on June 25, ultimately deciding that while the spread did not warrant the PHEIC label, it was to be “closely monitored.” Tedros said that the committee will meet during the week of July 18 or sooner, if needed.

Embed from Getty Images

“I continue to be concerned by the scale and spread of the virus across the world,” Tedros said, also noting that due to testing being a “challenge,” more cases that are going unreported is a strong possibility. He explained monkeypox is occuring in African countries previously not affected, while record numbers are appearing in countries that have had past experience with the virus.

PHEIC is defined by the WHO as an extraordinary event that sees a “public health risk to other States through the international spread of disease” which requires a worldwide coordinated response. Since 2009, there have been six PHIEC’s declared by WHO, the most recent being COVID-19.

The hotbed for monkeypox currently resides in Europe, where 80% of lab-confirmed cases have been since mid-May. As of July 7, Germany leads all countries with 1,385 confirmed cases, while the United Kingdom sits in second with 1,351 cases.

The United States sits fourth with 699 confirmed cases, 20% (122) of which are located in New York — specifically New York City, where cases doubled from 55 last week. 33 states, including Washington, D.C. and Puerto Rico, have at least one confirmed case.

Embed from Getty Images

Part of the same family as smallpox, monkeypox symptoms can include fevers, chills, a lack of energy, headaches, muscles aches, and skin lesions on the arms, face, and legs. While these can last for up to three or four weeks, the disease is rarely fatal, with recent mortality rates ranging from 3% to 6%.

In addition to spreading through direct contact with rashes and and body fluids, the virus can enter the body through respiratory secretions during face-to-face contact or intimate physical contact.

Health officials have explained the majority of cases are found in gay or bisexual men who have had contact with other men. Tedros explained that because of this, WHO is prioritizing working with the LGBTQ+ community in order to emphasize prevention.

“WHO is also working closely with civil society and LGBTQI+ community, especially to break the stigma around the virus and spread information so people can protect themselves.”

Action against the virus has already begun, with the U.S. Department of Health and Human Services (HHS) reporting it ordered an additional 2.5 million doses of the JYNNEOS monkeypox vaccine on July 1, bringing the federal government’s available supply to 4 million.

“We will continue to be responsive to jurisdictions and deliver vaccine as quickly as we can while we maintain a focus on fair and equitable distribution nationwide,” HHS Assistant Secretary for Preparedness and Response Dawn O’Connell said, with the Biden Administration’s strategy for distribution focusing on locations with the most at-risk and highest case rates.

The vaccine distributions have seen their highest totals in California, New York, and Illinois, particularly in the states’ major cities: Los Angeles (7,346), New York City (7,169), and Chicago (5,409). Massachusetts are Colorado have also seen sizeable distribution.

Clinical Trial

A Small Cancer Trial Resulted In Remission For Every Patient Involved 

In a new research trial of 18 rectal cancer patients, every individual involved who took the same drug found themselves in remission for their illness. The cancer vanished in every single patient, meaning the cancer was undetectable by physical exam, endoscopy, MRI scans, and PET scans. 

The research from the trial was recently published in the New England Journal of Medicine from lead author Dr. Luiz A. Diaz Jr. of the Memorial Sloan Kettering Cancer Center. The trial was sponsored by drug company GlaxoSmithKline, and Dr. Diaz stated that he knew of no other study where a treatment completely obliterated a cancer in every patient involved. 

Embed from Getty Images

“I believe this is the first time this has happened in the history of cancer.”

Dr. Alan P. Venook, a colorectal cancer specialist at the University of California, San Francisco, who was not involved with the study, said he also thought “this was a first. A complete remission in every single patient is unheard-of,” he said.

The rectal cancer patients involved in the study have all previously experienced invasive and intense treatments for their conditions including chemotherapy, radiation, and life-altering surgery that could result in bowel, urinary, and sexual dysfunction. 

When the patients received the news that they would no longer need treatment for their cancer, as it was no longer existent, Dr. Andrea Cercek, a co-author of the paper, said “there was a lot of happy tears from everyone.”

Embed from Getty Images

Venook added that another major surprise was that none of the patients had any clinically significant complications from the trial drug. On average 20% of patients who take a drug similar to the one used in the trial, dostarlimab, have some sort of adverse reaction. 

In the trial the medication was given every three weeks for six months, each dose cost around $11,000. The drug itself is meant to “unmask” cancer cells, allowing the body’s immune system to easily identify and destroy them. 

“While most adverse reactions are easily managed, as many as 3% to 5% of patients who take checkpoint inhibitors have more severe complications that, in some cases, result in muscle weakness and difficulty swallowing and chewing. The absence of significant side effects, means that either they did not treat enough patients or, somehow, these cancers are just plain different,” Venook said.

Dr. Hanna K. Sanoff of the University of North Carolina’s Lineberger Comprehensive Cancer Center, who was not involved in the study, called it “small but compelling, though, that it is not clear if the patients are cured. Very little is known about the duration of time needed to find out whether a clinical complete response to dostarlimab equates to cure.”

Florida Officials Investigating U.S.’ Third Possible Monkeypox Case

Florida health officials are currently investigating what they call a “presumptive” monkeypox case, which would make it the third possible case in the U.S. as the disease continues to see afflictions worldwide.

According to a press release by the Florida Department of Health, the investigation is being led by the Florida Department of Health in Broward County (DOH Broward), along with the Bureau of Public Health Laboratories and the Centers for Disease Control and Prevention (CDC).

The release noted the infection is related to international travel, while the person remains in isolation. DOH Broward — which is conducting epidemiological investigations to notify possible exposures — has not identified any additional cases.

Embed from Getty Images

On May 20, two days before the announcement of the investigation, the CDC issued a health advisory regarding recent cases in the United States. The first monkeypox case was identified on May 18, when the Massachusetts-based patient displayed skin lesions that had several features — firm, well circumscribed, and umbilicated — relating to the disease. A man in New York City is also being monitored for exhibiting a Monkeypox consistent illness.

Across the globe, more and more countries are seeing cases popping up. There is now 190 confirmed or suspected cases across 16 countries where the disease is not normally found. Spain confirmed the capital of Madrid had 30 cases Monday, while Germany has four confirmed cases.

The World Health Organization’s (WHO) lead advisor Dr. David Heymann called the outbreak a “random event,” stating it could have been amplified by sexual activities at two raves in Europe.

“We know monkeypox can spread when there is close contact with the lesions of someone who is infected, and it looks like sexual contact has now amplified that transmission.”

A zoonotic endemic discovered back in 1958, Monkeypox has historically circulated throughout central and west African countries. However, the recent transmission of cases through sexual contact is different from past cases that have been transmitted through wild rodents and primates.

According to the CDC, symptoms of Monkeypox always include the characteristic rash, which can be followed by fevers, malaise, muscle aches, and lymphadenopathy. With recent cases including lesions in the genital and perianal regions, it could be mistaken for sexually transmitted diseases like syphilis or herpes.

Researchers believe the human-to-human transmission of Monkeypox is through “inhalation of large respiratory droplets,” rather than contact with bodily fluids or indirect contact through clothing. It can also enter through broken skin or mucous membranes in the eyes, nose, or mouth.

Embed from Getty Images

Still, the illnesses caused by Monkeypox are mild, while no deaths related to the cases have been reported thus far. In recent times, the fatality rate of Monkeypox has hovered around 3% to 6%.

Additionally, those who catch the virus usually recover over two to four weeks. Those factoids have contributed to the lack of concern by leaders like President Joe Biden, who commented on Monkeypox during his press conference in Tokyo Monday.

“I just don’t think it rises to the level of the kind of concern that existed with COVID-19, and the smallpox vaccine works for it,” Biden said, adding that the U.S. has enough of the vaccine to deal with any potential outbreaks. The response was more laid back than Biden’s previous comments on Monkeypox, where he called it something “everyone should be worried about.”

Similar to COVID-19 protocols, the WHO advised those who contract Monkeypox and are showing symptoms to remain isolated and avoid contact, and for anyone around the infected individual to wear a mask while thoroughly cleaning hands surfaces.